Pricing Log in Create free account

Akanda Corp. (AKAN) vs Sunshine Biopharma, Inc. (SBFM)

Akanda Corp. and Sunshine Biopharma, Inc. are both Drug Manufacturers Specialty & Generic companies. Akanda Corp. and Sunshine Biopharma, Inc. are of similar size ($2.2M and $2.1M). Across the 10 metrics below, Akanda Corp. leads on 7 and Sunshine Biopharma, Inc. on 3.

Valuation

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
P/E — n/m 20.55
P/S — 0.01 2.08
P/B n/m 0.01 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m 2.40 12.22
EV/Sales n/m (0.33) 2.87
Earnings yield — (6,843.57%) (15.94%)
Free cash flow yield 0.00% (2,844.26%) 0.00%

Profitability

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Gross margin — 30.30% 53.51%
Operating margin — (16.65%) 0.00%
Net margin — (16.50%) (2.45%)
Free cash flow margin 0.00% (15.66%) 0.00%
Return on equity 0.00% (21.93%) (0.80%)
Return on assets 0.00% (17.78%) (1.67%)
Return on invested capital 0.00% (26.67%) 0.00%

Growth

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (2.74%) 5.22%
EPS growth (last fiscal year) (139.63%) 80.35% 42.91%
Revenue growth, 5-year CAGR 161.77% 247.74% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Debt to equity (0.70) 0.00 0.04
Current ratio 0.22 5.46 2.41
Net debt to EBITDA (2.75) 2.20 1.01

Dividend

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKAN SBFM Drug Manufacturers Specialty & Generic median
Market cap 2.24m 2.13m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack